---
title: Impact of technological advances like CRISPR and pluripotent stem cells on aging research
videoId: 9ufjpKUYNIE
---

From: [[foundmyfitness]] <br/> 

The SENS Research Foundation, founded by biomedical gerontologist Dr. Aubrey de Grey, aims to prevent and cure aging <a class="yt-timestamp" data-t="00:00:11">[00:00:11]</a>, <a class="yt-timestamp" data-t="00:00:24">[00:00:24]</a>. Dr. de Grey characterizes aging as the inevitable accumulation of various molecular and cellular changes, or "damage," that the body cannot fully repair <a class="yt-timestamp" data-t="00:01:08">[00:01:08]</a>, <a class="yt-timestamp" data-t="00:01:25">[00:01:25]</a>, <a class="yt-timestamp" data-t="00:03:08">[00:03:08]</a>. This damage eventually exceeds the body's tolerance, leading to mental and physical decline, and the diseases and disabilities associated with old age <a class="yt-timestamp" data-t="00:01:36">[00:01:36]</a>.

The fundamental clock of aging is the accumulation of damage that the body simply lacks the genetic capability to repair, even in youth <a class="yt-timestamp" data-t="00:04:29">[00:04:29]</a>, <a class="yt-timestamp" data-t="00:04:35">[00:04:35]</a>. This unrepaired damage then accelerates the creation of new damage and impedes existing repair mechanisms <a class="yt-timestamp" data-t="00:04:42">[00:04:42]</a>. The SENS approach focuses on developing interventions to periodically repair these various types of damage, keeping the overall level below the harmful threshold <a class="yt-timestamp" data-t="00:02:56">[00:02:56]</a>, <a class="yt-timestamp" data-t="00:03:01">[00:03:01]</a>.

## Advancements in Gene Editing: CRISPR

The advent of [[advancements_in_gene_therapies_for_diseases_and_aging | gene editing technologies]] like [[crispr_and_gene_therapy_for_disease_and_longevity | CRISPR]] has significantly impacted aging research <a class="yt-timestamp" data-t="00:15:16">[00:15:16]</a>, <a class="yt-timestamp" data-t="00:34:25">[00:34:25]</a>. [[crispr_and_gene_therapies_for_disease_and_longevity | CRISPR]] allows scientists to specifically target a gene, excise it, and replace it with a more or less active version <a class="yt-timestamp" data-t="00:15:21">[00:15:21]</a>. Dr. de Grey highlights [[crispr_and_gene_therapy_for_disease_and_longevity | CRISPR]] as a "particularly important advance" for its role in enabling the genetic modifications necessary for comprehensive damage repair <a class="yt-timestamp" data-t="00:34:43">[00:34:43]</a>, <a class="yt-timestamp" data-t="00:34:48">[00:34:48]</a>.

Traditionally, somatic gene therapy has faced challenges in safety due to the difficulty in controlling where viral vectors insert engineered DNA, potentially leading to cancer <a class="yt-timestamp" data-t="00:35:08">[00:35:08]</a>. However, [[crispr_and_gene_therapy_for_disease_and_longevity | CRISPR]] stands out due to its high site-specificity and fidelity, which has rapidly improved over time <a class="yt-timestamp" data-t="00:35:39">[00:35:39]</a>, <a class="yt-timestamp" data-t="00:35:44">[00:35:44]</a>, <a class="yt-timestamp" data-t="00:35:48">[00:35:48]</a>. This allows for an increased amount of engineered DNA (titer) and a higher proportion of modified cells (penetrance) without increasing unwanted off-target effects <a class="yt-timestamp" data-t="00:35:54">[00:35:54]</a>, <a class="yt-timestamp" data-t="00:36:05">[00:36:05]</a>. While [[crispr_and_gene_therapy_for_disease_and_longevity | ex vivo]] (outside the body) gene editing of cells, such as [[stem_cell_applications_in_treating_diseases | stem cells]] for reinjection, is easier <a class="yt-timestamp" data-t="00:34:57">[00:34:57]</a>, <a class="yt-timestamp" data-t="00:36:33">[00:36:33]</a>, challenges remain in precisely targeting specific tissues like the liver, heart, or muscle within the body <a class="yt-timestamp" data-t="00:36:23">[00:36:23]</a>, <a class="yt-timestamp" data-t="00:36:35">[00:36:35]</a>.

## The Promise of Pluripotent Stem Cells

Another significant technological advance is the ability to create [[stem_cell_applications_in_treating_diseases | induced pluripotent stem cells]] (iPSCs) <a class="yt-timestamp" data-t="00:37:01">[00:37:01]</a>. This involves taking a somatic cell, such as a skin cell, and genetically reprogramming it to become a pluripotent [[stem_cell_applications_in_treating_diseases | stem cell]] capable of forming any cell type in the body <a class="yt-timestamp" data-t="00:37:05">[00:37:05]</a>, <a class="yt-timestamp" data-t="00:37:12">[00:37:12]</a>.

Early methods for inducing pluripotency often involved viruses <a class="yt-timestamp" data-t="00:37:25">[00:37:25]</a>, but more recent advancements have allowed for non-viral methods, such as using messenger RNA or electroporating proteins directly into cells <a class="yt-timestamp" data-t="00:37:27">[00:37:27]</a>, <a class="yt-timestamp" data-t="00:37:42">[00:37:42]</a>. While the efficiency of these methods can still be low, it is improving <a class="yt-timestamp" data-t="00:37:55">[00:37:55]</a>.

A key aspect of [[the_potential_of_epigenetic_reversal_in_antiaging_research | iPSC technology]] for aging research is the quality of reprogramming. Standard methods for creating iPSCs do not entirely erase the original [[epigenetics_and_aging | epigenetic]] state of the cell, leading to some "epigenetic memory" <a class="yt-timestamp" data-t="00:40:02">[00:40:02]</a>, <a class="yt-timestamp" data-t="00:40:08">[00:40:08]</a>, <a class="yt-timestamp" data-t="00:40:16">[00:40:16]</a>. However, newer techniques, such as using six specific factors instead of the original Yamanaka factors, have been shown to achieve a much higher fidelity in reprogramming, even enabling the reprogramming of senescent cells <a class="yt-timestamp" data-t="00:38:04">[00:38:04]</a>, <a class="yt-timestamp" data-t="00:38:09">[00:38:09]</a>, <a class="yt-timestamp" data-t="00:38:15">[00:38:15]</a>. Researchers are continuously seeking ways to further eliminate this [[epigenetic aging and diseases | epigenetic]] memory <a class="yt-timestamp" data-t="00:40:25">[00:40:25]</a>.

The ultimate goal for therapeutic application is autologous administration: taking cells from a person, reprogramming them, modifying them as needed, and reinjecting them back into the same person <a class="yt-timestamp" data-t="00:39:10">[00:39:10]</a>, <a class="yt-timestamp" data-t="00:39:18">[00:39:18]</a>. While currently expensive due to its personalized nature, advancements are expected to reduce costs and make this approach more feasible in the future <a class="yt-timestamp" data-t="00:39:26">[00:39:26]</a>.

## Limitations and Future Outlook

While these technologies represent significant [[advancements_in_gene_therapies_for_diseases_and_aging | advancements]], it's crucial to distinguish between adapting to aging and directly addressing the aging process itself <a class="yt-timestamp" data-t="00:07:02">[00:07:02]</a>. For example, some [[epigenetics_and_aging | epigenetic changes]] seen in aging are adaptations that help minimize pathogenic consequences, rather than being a primary cause of aging <a class="yt-timestamp" data-t="00:07:12">[00:07:12]</a>, <a class="yt-timestamp" data-t="00:07:17">[00:07:17]</a>. Research utilizing single-cell analysis is necessary to quantify "noise" or variation in [[epigenetic aging and diseases | epigenetic changes]] that occurs without genetic direction, providing insights into actual aging processes versus adaptations <a class="yt-timestamp" data-t="00:08:05">[00:08:05]</a>, <a class="yt-timestamp" data-t="00:08:10">[00:08:10]</a>, <a class="yt-timestamp" data-t="00:08:17">[00:08:17]</a>.

The SENS Research Foundation's focus remains on repairing accumulated damage as the core strategy to combat aging <a class="yt-timestamp" data-t="00:34:01">[00:34:01]</a>. While lifestyle factors and nutrition can influence [[impact_of_lifestyle_factors_on_epigenetic_aging | health and lifespan]], their impact on maximum longevity is relatively small compared to addressing the fundamental biological damage of aging <a class="yt-timestamp" data-t="00:29:49">[00:29:49]</a>, <a class="yt-timestamp" data-t="00:30:27">[00:30:27]</a>. Technologies like [[crispr_and_gene_therapy_for_disease_and_longevity | CRISPR]] and [[stem_cell_applications_in_treating_diseases | pluripotent stem cells]] are seen as crucial tools that accelerate the research and development of these damage-repair interventions, making the goal of comprehensive aging remediation more attainable <a class="yt-timestamp" data-t="00:34:29">[00:34:29]</a>.